Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$1.39B |
| 2 |
Charter Communications
CHTR
|
+$1.21B |
| 3 |
Abbott
ABT
|
+$1.07B |
| 4 |
Intel
INTC
|
+$704M |
| 5 |
Meta Platforms (Facebook)
META
|
+$687M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.03B |
| 2 |
Illumina
ILMN
|
+$1.01B |
| 3 |
Comcast
CMCSA
|
+$995M |
| 4 |
Norfolk Southern
NSC
|
+$590M |
| 5 |
Home Depot
HD
|
+$581M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.42% |
| 2 | Healthcare | 15.61% |
| 3 | Financials | 12.61% |
| 4 | Communication Services | 11.28% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLIBA
351
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $14.3M | 0.01% |
232,600
| – | – |
|
|
WMGI
352
DELISTED
Wright Medical Group Inc
WMGI
| $13.9M | 0.01% |
465,000
| – | – |
|
353
Flex
FLEX
$46.7B
| $13.3M | 0.01% |
+1,850,369
| New | +$14.2M |
|
354
AngloGold Ashanti
AU
$48.2B
| $12M | ﹤0.01% |
+672,208
| New | +$9.02M |
|
|
CEO
355
DELISTED
CNOOC Limited
CEO
| $11.9M | ﹤0.01% |
70,100
-14,300
| -17% | -$2.49M |
|
356
Petrobras Class A
PBR.A
$103B
| $11.9M | ﹤0.01% |
836,802
-2,945
| -0.4% | -$40.5K |
|
357
First Hawaiian
FHB
$3.39B
| $11.8M | ﹤0.01% |
456,500
| – | – |
|
|
AZUL
358
DELISTED
Azul
AZUL
| $11.7M | ﹤0.01% |
350,700
| – | – |
|
359
Zebra Technologies
ZBRA
$18.1B
| $11.5M | ﹤0.01% |
55,000
| – | – |
|
360
General Motors
GM
$76B
| $11.1M | ﹤0.01% |
288,211
+173
| +0.1% | +$6.49K |
|
361
Xenon Pharmaceuticals
XENE
$6.31B
| $10.4M | ﹤0.01% |
1,055,726
| – | – |
|
362
STAAR Surgical
STAA
$1.23B
| $10.3M | ﹤0.01% |
+350,800
| New | +$10.1M |
|
363
AnaptysBio
ANAB
$1.68B
| $9.12M | ﹤0.01% |
161,700
| – | – |
|
|
GRFS
364
Grifois
GRFS
$5.41B
| $8.57M | ﹤0.01% |
406,315
-1,539
| -0.4% | -$29.4K |
|
365
Itaú Unibanco
ITUB
$81.9B
| $7.93M | ﹤0.01% |
1,157,658
| – | – |
|
|
AUTL
366
Autolus Therapeutics
AUTL
$551M
| $7.87M | ﹤0.01% |
488,888
| – | – |
|
367
Brookfield
BN
$109B
| $7.67M | ﹤0.01% |
+449,093
| New | +$7.6M |
|
|
CZZ
368
DELISTED
Cosan Limited
CZZ
| $7.6M | ﹤0.01% |
569,000
| – | – |
|
|
SAND
369
DELISTED
Sandstorm Gold
SAND
| $7.54M | ﹤0.01% |
1,361,300
| – | – |
|
370
Artivion
AORT
$1.39B
| $6.95M | ﹤0.01% |
232,174
| – | – |
|
|
CLLS
371
Cellectis
CLLS
$312M
| $6.56M | ﹤0.01% |
+420,692
| New | +$7.51M |
|
|
RUBY
372
DELISTED
Rubius Therapeutics, Inc
RUBY
| $6.55M | ﹤0.01% |
416,396
| – | – |
|
373
CRISPR Therapeutics
CRSP
$5.26B
| $6.5M | ﹤0.01% |
138,000
| – | – |
|
|
ADSW
374
DELISTED
Advanced Disposal Services Inc
ADSW
| $6.22M | ﹤0.01% |
195,000
-2,334,671
| -92% | -$73.5M |
|
|
GNFT
375
DELISTED
Genfit
GNFT
| $4.88M | ﹤0.01% |
+247,100
| New | +$5.78M |
|
Similar funds
Capital International Investors's Q2 2019 Portfolio in Review
As of Q2 2019, Capital International Investors held 419 positions worth $251B, up 7.7% from $233B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Capital International Investors deployed $8.34B of net new capital in Q2 2019, opening 35 new positions and adding to 204 existing holdings. Its largest new stake was Dow Inc: 26,359,397 shares worth $1.3B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $1.03B trimmed.
- Capital International Investors's largest Q2 2019 buy was Dow Inc: 26,359,397 shares worth $1.3B.
- Capital International Investors added most to Charter Communications in Q2 2019, an estimated $1.21B increase.
- Capital International Investors's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $1.03B.
- Capital International Investors fully exited Baidu in Q2 2019, selling an estimated $312M.
- Capital International Investors's ten largest holdings make up 26% of its $251B portfolio in Q2 2019.
- Capital International Investors opened 35 new positions and closed 31 in Q2 2019.
- Capital International Investors's portfolio value rose 7.7% quarter-over-quarter to $251B.
Based on Capital International Investors's 13F filing for Q2 2019, filed 14 Aug 2019.